Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

RXRX

Market Cap$2.11B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Recursion Pharmaceuticals Inc - Ordinary Shares - Class ARecursion Pharmaceuticals Inc - Ordinary Shares - Class A-3.7--62%-0.1

Share Statistics

Market cap$2.11 Billion
Enterprise Value$1.74 Billion
Dividend Yield$0 (0%)
Earnings per Share$-1.69
Beta0.83
Outstanding Shares402,771,972

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-3.69
PEG-3.04
Price to Sales-
Price to Book Ratio2.8
Enterprise Value to Revenue29.09
Enterprise Value to EBIT-3.06
Enterprise Value to Net Income-4
Total Debt to Enterprise0.08
Debt to Equity0.14

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Recursion Pharmaceuticals Inc

218 employees

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patient...